Skip to main content

Serum Osteocalcin bei Patienten mit chronischer Polyarthritis vor und nach Basistherapie mit Gold oder Methotrexat

  • Conference paper
Osteologie aktuell VIII
  • 50 Accesses

Zusammenfassung

Der Knochenstoffwechsel bei Patienten mit chronischer Polyarthritis (CP) wird durch zahlreiche Faktoren beeinflußt. Die Pathogenese wird kontrovers diskutiert [1, 2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Sambrook PN, Shawe D, Hesp R, Zanelli JM et al. (1990) Rapid periartieular bone loss in rheumatoid arthritis. Arthr Rheum 33: 615–622

    Article  CAS  Google Scholar 

  2. Als OS, Christiansen C, Heilesen C (1984) Prevalence of decreased bone mass in rheumatoid arthritis. Relation to anti-inflammatory treatment. Clin Rheumatol 3: 201–208

    CAS  Google Scholar 

  3. Triffitt JT (1987) The special proteins of bone tissue. Clin Science 72: 399–408

    CAS  Google Scholar 

  4. Ekenstam EA, Ljunghall S, Hallgren R (1986) Serum osteocalcin in rheumatoid arthritis and other inflammatory arthritides: relation between inflammatory activity and the effect of glucocorticoids and remission inducing drugs. Ann Rheum Dis 45: 484–490

    Article  PubMed  CAS  Google Scholar 

  5. Eastgate JA, Wood NC, di Giovine FS et al. (1988) Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet II:706–709

    Google Scholar 

  6. Gowen M, Wood DD, Ihrie E, McGuire M, Russell RGG (1983) An interleukin 1-like fak-tor stimulates bone résorption in vitro. Nature 306: 378–380

    Article  PubMed  CAS  Google Scholar 

  7. Beresford JN, Gallagher JA, Poser JW, Russell RGG (1984) Production of Osteocalcin by Human Bone Cells in Vitro. Effects of 1.25(OH)2D3, Parathyroid Hormone and Glucocorticoids. Metab Bone Dis Rel Res 5: 229–234

    Article  CAS  Google Scholar 

  8. Weisman MH, Orth RV, Catherwood BD, Manalagas SC, Deftos LJ (1986) Measures of Bone Loss in Rheumatoid Arthritis. Arch Intern Med 146: 701–704

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Franck, H., Ittel, T.H., Tasch, O., Herborn, G., Rau, R. (1994). Serum Osteocalcin bei Patienten mit chronischer Polyarthritis vor und nach Basistherapie mit Gold oder Methotrexat. In: Reiser, M., Heuck, A., Münzenberg, K.J., Kummer, B. (eds) Osteologie aktuell VIII. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78676-1_53

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78676-1_53

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-57497-2

  • Online ISBN: 978-3-642-78676-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics